image
Healthcare - Medical - Diagnostics & Research - NASDAQ - US
$ 36.89
-5.31 %
$ 2.16 B
Market Cap
-9.66
P/E
CASH FLOW STATEMENT
-142 M OPERATING CASH FLOW
-14.54%
50.6 M INVESTING CASH FLOW
121.73%
911 K FINANCING CASH FLOW
-99.66%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Twist Bioscience Corporation
image
Net Income -205 M
Depreciation & Amortization 29.3 M
Capital Expenditures -27.8 M
Stock-Based Compensation 30.3 M
Change in Working Capital -1.01 M
Others 2.56 M
Free Cash Flow -170 M

Cash Flow

Millions
Sep-2023 Sep-2022 Sep-2021 Sep-2020 Sep-2019 Sep-2018 Sep-2017 Sep-2016
OPERATING CASH FLOW
Net Income (204.6) (217.9) (152.1) (139.9) (107.7) (71.2) (59.3) (44.1)
Depreciation & Amortization 29.3 16.5 9.8 6.7 6.1 5.7 5.0 4.2
Deferred Income Tax (0.4) 0 0.6 (0.2) (1.1) 42 K 0.8 68 K
Stock Based Compensation 30.3 79.7 37.0 17.1 11.2 3.0 1.9 0.9
Other Operating Activities 4.0 2.7 1.9 (0.7) 0.5 0.6 0.5 0.2
Change in Working Capital (1.0) (5.4) (9.4) (25.2) 3.0 (4.2) (0.1) 0.2
Cash From Operations (142.5) (124.4) (112.2) (142.3) (87.9) (66.2) (51.3) (38.6)
INVESTING CASH FLOW
Capital Expenditures (27.8) (101.9) (27.1) (9.9) (14.8) (3.7) (6.6) (6.2)
Other Items 78.4 (131.1) 183.2 (104.8) (90.1) 30.6 (3.3) (27.1)
Cash From Investing Activities 50.6 (232.9) 156.2 (114.7) (104.8) 26.9 (9.9) (33.3)
FINANCING CASH FLOW
Common Stock Repurchased (4.4) (7.8) (10.8) (2.4) 0 0 0 0
Total Debt Repaid 0 (1.6) (3.3) (3.3) (2.5) 0 (2.0) 7.2
Dividends Paid 0 0 0 0 0 0 0 0
Other Financing Activities 5.3 10.0 19.5 13.9 4.9 88.8 65.8 124.7
Cash From Financing Activities 0.9 270.5 329.2 303.7 158.6 88.8 63.8 69.6
CHANGE IN CASH
Net Change In Cash (91.0) (87.1) 373.1 46.8 (34.1) 49.5 2.6 (2.3)
FREE CASH FLOW
Free Cash Flow (170.3) (226.2) (139.3) (152.1) (102.7) (69.9) (57.9) (44.8)